Markets@2014: Top investment ideas by Raamdeo Agrawal
Raamdeo Agrawal thinks that IT sector is going to remain at the forefront in the year 2014 along with policy-centric stocks.
Mid-cap pharma stocks can return 20% in 2014, say analysts
Elara Capital in a report said that they expect revenues to grow at a robust 20 per cent, driven by continued strong performance by Sun Pharma.
Credit Suisse overweight on India; bets on HCL, Wipro, Tata Motors
The investment bank is of the view that valuations, EPS revisions and rise in US bond yields suggest further cyclicalsâ outperformance.
|
No comments:
Post a Comment